How big is the remicade market?

The global remicade market size was estimated at USD 3.04 billion in 2024 and is expected to reach USD 2.94 billion in 2025.

What is the remicade market growth?

The global remicade market is expected to decline at a compound annual growth rate of -2.28% from 2025 to 2030 to reach USD 2.62 billion by 2030.

Which segment accounted for the largest remicade market share?

Based on type, Branded Remicade segment dominated the remicade market, accounting for 52.8 % of the share in 2024, due to Janssen's strong market position. This share can be attributed to its established product efficacy in treating autoimmune conditions like Crohn's disease and ulcerative colitis.

Who are the key players in the remicade market?

Key players operating in the market are Janssen Pharmaceuticals (Johnson & Johnson), Celltrion, Pfizer Inc., Samsung Bioepis, Novartis AG

What are the factors driving the remicade market?

The growth of the Remicade market is primarily driven by the rise of cost-effective biosimilars following patent expirations, as well as the growing preference for newer biologic therapies.